High Tower Advisors, LLC Novartis Ag Transaction History

High Tower Advisors, LLC

  • $68.3 Billion
  • Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, High Tower Advisors, LLC holds 290,860 shares of NVS stock, worth $30.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
290,860
Previous 295,848 1.69%
Holding current value
$30.2 Million
Previous $31.5 Million 6.22%
% of portfolio
0.05%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$106.13 - $120.89 $529,376 - $602,999
-4,988 Reduced 1.69%
290,860 $33.5 Million
Q2 2024

Aug 13, 2024
SELL
$92.57 - $107.37 $37,490 - $43,484
-405 Reduced 0.14%
295,848 $31.5 Million
Q1 2024

May 06, 2024
BUY
$95.27 - $108.47 $693,946 - $790,095
7,284 Added 2.52%
296,253 $28.7 Million
Q4 2023

Feb 12, 2024
BUY
$92.27 - $101.54 $587,667 - $646,708
6,369 Added 2.25%
288,969 $29.2 Million
Q3 2023

Nov 08, 2023
BUY
$94.73 - $105.13 $1.84 Million - $2.04 Million
19,435 Added 7.39%
282,600 $28.8 Million
Q2 2023

Aug 14, 2023
BUY
$92.52 - $104.91 $1.03 Million - $1.17 Million
11,116 Added 4.41%
263,165 $26.6 Million
Q1 2023

May 11, 2023
BUY
$80.03 - $92.81 $448,968 - $520,664
5,610 Added 2.28%
252,049 $23.2 Million
Q4 2022

Feb 08, 2023
BUY
$75.55 - $92.52 $166,210 - $203,544
2,200 Added 0.9%
246,439 $22.4 Million
Q3 2022

Nov 09, 2022
BUY
$74.61 - $87.26 $45,810 - $53,577
614 Added 0.25%
244,239 $18.6 Million
Q2 2022

Aug 10, 2022
SELL
$80.52 - $93.75 $4.55 Million - $5.3 Million
-56,517 Reduced 18.83%
243,625 $20.6 Million
Q1 2022

May 12, 2022
SELL
$80.11 - $90.62 $484,745 - $548,341
-6,051 Reduced 1.98%
300,142 $26.3 Million
Q4 2021

Feb 10, 2022
SELL
$79.7 - $88.13 $185,860 - $205,519
-2,332 Reduced 0.76%
306,193 $26.7 Million
Q3 2021

Nov 12, 2021
SELL
$81.78 - $95.14 $273,145 - $317,767
-3,340 Reduced 1.07%
308,525 $25.2 Million
Q2 2021

Aug 06, 2021
BUY
$85.24 - $94.15 $1.09 Million - $1.2 Million
12,734 Added 4.26%
311,865 $28.5 Million
Q1 2021

May 10, 2021
BUY
$83.5 - $98.47 $1.33 Million - $1.57 Million
15,942 Added 5.63%
299,131 $25.5 Million
Q4 2020

Feb 10, 2021
BUY
$78.07 - $94.43 $3.12 Million - $3.77 Million
39,934 Added 16.42%
283,189 $26.8 Million
Q3 2020

Nov 13, 2020
BUY
$82.14 - $91.0 $2.07 Million - $2.29 Million
25,153 Added 11.53%
243,255 $21.1 Million
Q2 2020

Aug 10, 2020
SELL
$80.93 - $91.1 $106,099 - $119,432
-1,311 Reduced 0.6%
218,102 $19 Million
Q1 2020

May 21, 2020
SELL
$70.67 - $99.01 $230,172 - $322,475
-3,257 Reduced 1.46%
219,413 $18 Million
Q4 2019

Feb 14, 2020
BUY
$84.35 - $95.37 $382,864 - $432,884
4,539 Added 2.08%
222,670 $21.1 Million
Q3 2019

Nov 12, 2019
BUY
$85.54 - $94.26 $388,009 - $427,563
4,536 Added 2.12%
218,131 $19 Million
Q2 2019

Aug 13, 2019
BUY
$75.4 - $92.8 $1.39 Million - $1.71 Million
18,413 Added 9.43%
213,595 $19.5 Million
Q1 2019

May 15, 2019
SELL
$75.32 - $86.15 $42,179 - $48,244
-560 Reduced 0.29%
195,182 $18.8 Million
Q4 2018

Feb 14, 2019
BUY
$73.66 - $82.02 $465,310 - $518,120
6,317 Added 3.33%
195,742 $16.8 Million
Q3 2018

Nov 09, 2018
SELL
$66.94 - $77.43 $316,693 - $366,321
-4,731 Reduced 2.44%
189,425 $16.3 Million
Q2 2018

Aug 14, 2018
SELL
$64.91 - $73.36 $346,554 - $391,669
-5,339 Reduced 2.68%
194,156 $14.7 Million
Q1 2018

May 15, 2018
SELL
$70.39 - $84.15 $1.33 Million - $1.59 Million
-18,954 Reduced 8.68%
199,495 $16.1 Million
Q4 2017

Feb 14, 2018
SELL
$72.33 - $77.64 $2.65 Million - $2.84 Million
-36,608 Reduced 14.35%
218,449 $18.3 Million
Q3 2017

Nov 14, 2017
SELL
$74.14 - $77.27 $97,419 - $101,532
-1,314 Reduced 0.51%
255,057 $21.9 Million
Q2 2017

Aug 14, 2017
BUY
N/A
256,371
256,371 $21.4 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email